Structure-Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy

Area of Science:

• Immunology
• Oncology
• Drug Discovery

Background:

• Immune checkpoint modulators, primarily monoclonal antibodies, are vital in cancer immunotherapy.
• Current treatments face limitations, including non-response in many patients and significant immune-related adverse effects.
• Small molecule immune modulators represent a promising alternative approach.

Purpose of the Study:

• To provide a critical analysis of the structural and dynamic details of key immune checkpoint receptors: CTLA-4, PD-1, and GITR.
• To examine the interactions between these receptors and their known modulators.
• To highlight the importance of structural information for designing novel small-molecule cancer therapeutics.

Main Methods:

• Literature review and critical analysis of existing structural and dynamic data for CTLA-4, PD-1, and GITR.
• Examination of published data on known immune checkpoint modulators and their binding interactions.
• Synthesis of structural insights to inform drug design strategies.

Main Results:

• Detailed structural and dynamic information for CTLA-4, PD-1, and GITR receptors is presented.
• Analysis reveals insights into the binding modes of various immune checkpoint modulators.
• The lack of structural data has previously hindered rational small-molecule drug design.

Conclusions:

• Understanding the structural and dynamic features of immune checkpoint receptors is crucial.
• This knowledge is essential for advancing the design of novel, targeted small-molecule anticancer drugs.
• The findings pave the way for more effective and safer cancer immunotherapies.